Sun Pharmaceutical Industries: Specialty and Domestic Formulation to Drive Growth.
Sun Pharma (SUNP) is expected to sustain steady growth momentum, driven by strong traction in its global specialty business (18% of sales)
481 Views
Sun Pharma - Addressing the Oral IL-23 Antagonist Challenge to Ilumya
Emkay Global Financial's research report on Sun Pharma J&J, in a recent investor interaction, had stated that its oral IL-23 receptor antagonist...
226 Views
Travel Food Services IPO - RHP Updates & Thoughts on Valuation
Travel Food Services (TFS) is looking to raise about US$233m in its India IPO. In this note, we will talk about the RHP updates and IPO valuations.
588 Views
Mankind Pharma Lock-Up - A US$1.1bn+ Lockup Release
The two pre-IPO investors have launched a block to sell around US$591m worth of Mankind Pharma shares. Since the lockup on the shares expired not...
796 Views
2023 High Conviction Update: Cipla (CIPLA IN)- Stellar Q1FY24 Performance; Margin Guidance Raised
Q1FY24 result beat expectations. Both India and the U.S. businesses reported record high revenue. EBITDA rose to multi-quarter high. For FY24,...
546 Views